% Expired Patents = 100.0

Forward Citations = 192

Loading Chart...

2 inventors (with patents filed for the assignee):

David John Miller (5 out of 39 patents)

William N Aldrich (5 out of 62 patents)

5 patents: Sort by Forward Citations

1. 7991474 - Methods and apparatus for testing disruption of a vagal nerve (2011-08-02),

2. 7962225 - Methods and apparatus for testing disruption of a vagal nerve (2011-06-14),

3. 7783358 - Methods and apparatus for treatment of obesity with an ultrasound device movable in two or three axes (2010-08-24),

4. 7684865 - Methods and apparatus for treatment of obesity (2010-03-23),

5. 7430449 - Methods and apparatus for testing disruption of a vagal nerve (2008-09-30),

Company Overview

Endovx, Inc. is a leading biotechnology company focused on developing innovative solutions for targeted drug delivery. Our proprietary technology enables precise delivery of therapeutics to specific areas of the body, improving treatment efficacy and minimizing side effects. With a commitment to improving patient outcomes, Endovx is revolutionizing the field of drug delivery.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#17 in Napa, CA

#12,070 in California

#51,620 in US

Napa, CA, United States of America

Endovx, Inc.

Forward Citations = 192

2 inventors:

David John Miller (5 out of 39 patents)

William N Aldrich (5 out of 62 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endovx, Inc.. Retrieved from https://idiyas.com/company/endovx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]